Statistics for Innovus Pharmaceuticals, (id:7852 INNV)

Valuation metrics

Market cap

712.49M

Enterprise value

766.54M

Trailing P/E (ttm)

-29.37

Forward P/E

65.75

PEG ratio

65.75

Price/Sales (ttm)

0.91

Price/Book (mrq)

2.73

Enterprise Value/Revenue

0.98

Enterprise Value/EBITDA

280.47

Overview

Shares outstanding

135.46M

Float

20.55M

Shares short

327.93K

% Held by insiders

0.85%

% Held by institutions

0.12%

Average volume (10 days)

41.58K

Average volume (90 days)

Price summary

52-Week low

3.52

52-Week high

6.69

52-Week change

-26.60%

Beta

0.38

50-Day moving average

5.84

200-Day moving average

5.22

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

June 30th, 2024

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-2.03%

Operating margin

-2.39%

Operational effectiveness

Return on assets

-2.02%

Return on equity

-6.03%

Income statement

Revenue (ttm)

5.79

Revenue per share (ttm)

5.79

Quarterly revenue growth (yoy)

Gross profit (ttm)

132.06M

EBITDA

1.15M

Net income to common (ttm)

-15,963,000.00

Diluted EPS (ttm)

-0.12

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

85.68M

Total cash per share (mrq)

0.63

Total debt (mrq)

109.95M

Total Debt/Equity (mrq)

37.82

Current ratio (mrq)

120.70%

Book value per share (mrq)

1.92

Cash flow

Cash flow statement

-11,429,000.00

Levered free cash flow (LFCF)

-16,347,375.00